Research Collaboration Agreement to screen thousands of known molecules against host targets building upon the Fenretinide (ISLA-101) discovery sourced from these laboratories that the Company has licensed for use against Flaviviruses


Research and development collaboration with Griffith University to screen for active anti-viral molecules in a rational repurposing strategy. The small molecule libraries for Drug Discovery (GRIDD) Compounds Australia facility, using highly sensitive assays.


Research collaboration agreement signed with Australia’s largest drug library containing approximately four and a half thousand molecules that can be searched for drug re-purposing and pipeline development


Cooperative Research and Development Agreement (CRADA) with the US Army in preparation for its Phase II clinical study for ISLA-101


Supply agreement with Catalent for manufacture of Fenretinide softgels for dengue fever trial participants


Right to reference National Cancer Institute IND for Isla101